ArticleScientific reports2025
RSM and ANN-GA assisted optimization of Morchella importuna extracts and their effects on antioxidant anticholinesterase and antiproliferative activity.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence-Assisted Optimization ofFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to determine the extraction conditions that maximize the biological activities of Morchella importuna and to demonstrate the pharmacological potential of the optimized extracts. Ultrasonic-assisted extraction was applied, and the effects of temperature, time, and solvent ratio were evaluated using Response Surface Methodology (RSM) and a hybrid Artificial Neural Network-Genetic Algorithm (ANN-GA) approach. ANN-GA optimization yielded higher levels of key phenolics, particularly quercetin, protocatechuic acid, and gallic acid, compared to RSM. The antioxidant capacities of the ANN-GA and RSM extracts were determined as TAS: 5.266 ± 0.015 and 5.101 ± 0.031 mmol/L, TOS: 8.144 ± 0.035 and 10.240 ± 0.054 µmol/L, OSI: 0.155 ± 0.001 and 0.201 ± 0.002, DPPH: 121.82 ± 1.30 and 113.26 ± 1.44 mg TE/g, and FRAP: 158.98 ± 0.91 and 141.87 ± 1.80 mg TE/g, respectively. ANN-GA extracts also showed stronger anticholinesterase activity with AChE inhibition values of 66.47 ± 0.85 µg/mL and BChE values of 119.16 ± 1.11 µg/mL. In antiproliferative assays, ANN-GA extracts exhibited higher cytotoxicity against A549, MCF-7, and DU-145 cell lines compared to RSM extracts. Overall, the ANN-GA-assisted optimization approach not only improved extraction efficiency but also enhanced the antioxidant, anticholinesterase, and antiproliferative properties of M. importuna. These findings highlight the potential of ANN-GA optimized extracts as promising natural candidates for functional food, nutraceutical, and future pharmaceutical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.